Funding from Foundations/Private Sources
JHU's Corporate and Foundation Relations maintains a Web site listing upcoming grant competitions that are sponsored by foundations and other private sources: http://jhuresearch.jhu.edu/OCFR.htm. They are in addition to the limited-submission RFPs periodically announced by the Research Projects Administration office. The opportunities are listed in order of deadline and links to each funder's application information are provided. Contact Joan Wisner-Carlson (firstname.lastname@example.org) with any questions.
The Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins is pleased to announce that funding is available for a limited number of novel developmental research programs (pilot projects) in the study of adenocarcinoma of the pancreas. This program funds important new pilot projects with promising translational potential that do not have sufficient data for an independently funded NIH grant. Projects of high priority should focus on new research directions, explore innovative ideas, test unconventional, but potentially important, new hypotheses, or ascertain the feasibility of new research approaches. Applications are due Thursday, September 1, 2011 at 5:00 p.m. For more information on how to submit an application visit: http://pilotprojects.onc.jhmi.edu.
Applicants who are interested in this program
should submit the above materials in one PDF document no later than
12 midnight on Monday, August 8, 2011, via e-mail to email@example.com.
Each applicant should expect to receive a confirmation of receipt of
their materials within 48 hours. If you do not receive an acknowledgement,
please contact Mike Alexander directly at (410) 516-8734. The internal
selection will be completed as soon as possible in order to give the
applicants sufficient time to prepare a letter of intent for submission
to NIH by August 21, 2011. The complete application is due by September
21, 2011. If you have any questions, please contact Mike Alexander (firstname.lastname@example.org;
It was recently announced there is $16 million available to the DoD-PRCRP to "improve the quality of life by decreasing the impact of cancer on service members, their families and the American public." The FY11 PRCRP "supports the next generation of cancer research by providing new investigators and their early career mentors opportunities to excel in groundbreaking cutting-edge research for the prevention, detection and treatment of cancer." The pre-application deadline is August 10, 2011. A detailed description of this funding opportunity can be found at: http://cdmrp.army.mil/funding/prcrp.shtml.
Letter of Intent Deadline : August 14, 2011
The National Institute of Neurological Disorders and Stroke (NINDS) announces its CounterACT cooperative research (U01) program in the area of translational research. The mission of this program is to develop new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare nerve agents such as sarin and VX, and toxic industrial chemicals and pesticides such as cyanide, chlorine, parathion, and sodium fluoroacetate. The scope of the research to be supported includes basic target and candidate identification and characterization studies, through candidate optimization and demonstration of in vivo efficacy, through Investigational New Drug (IND) submission and Phase 1 clinical trials when appropriate. Each project must include milestones that create discrete go or no-go decision points in a progressive translational study plan. For complete details on this funding opportunity, click here: http://grants.nih.gov/grants/guide/pa-files/PAR-11-155.html.
NINDS has a listing of Translational Research opportunities available on their website at the following page: http://www.ninds.nih.gov/funding_announcements/Translational-Research.htm
Please submit the documents as one PDF in the
Each applicant should expect to receive
a confirmation of receipt of their materials within 48 hours. If you
do not receive such an acknowledgement, please contact Karen Falter
directly at: (410) 502-2132 or by e-mail.
Selected candidates will be notified as soon as possible. Completed
applications must be received by NFL Charities via the online application
process no later than Thursday, September 15, 2011.
The FY11 PRORP challenges the scientific community to address the most significant gaps in care for the leading burden of injury and loss of fitness for military duty by funding innovative, high-impact, clinically relevant research to advance optimal treatment and rehabilitation from musculoskeletal injuries sustained during combat or combat-related activities. All applications for PRORP funding must specifically address at least one of the topic areas as directed by Congress, and must be directly relevant to the health care needs of the military service members, veterans, and/or beneficiaries. Please use the following link to retrieve the eligibility requirements, deadlines and additional details for each award mechanism listed below.
All applications must conform to the program announcements and application instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application will be required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline of September 7, 2011. Applications must be submitted through the federal government's single-entry portal, Grants.gov. Requests for email notification of the program announcements release may be sent to email@example.com. For more information about the PRORP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).